This inventor holds 4 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignees: The Weizmann Institute of Science, Yeda Research and Development Co. Ltd, Yeda Research and Develpment & Co. Ltd. Active years: 2010-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 49 
1 out of 29 
1 out of 1,168 Years Active: 2010-2026
Title: Diego Jaitin: Innovator in RNA Sequencing and Cancer Treatment
Introduction
Diego Jaitin is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the fields of RNA sequencing and cancer treatment through his innovative patents. With a total of 4 patents, Jaitin's work is at the forefront of scientific research and development.
Latest Patents
Among his latest patents is CRISP-seq, an integrated method for massively parallel single-cell RNA-seq. This groundbreaking technology allows for the analysis of gene expression at the single-cell level, providing insights into cellular functions and disease mechanisms. Another notable patent involves CRISPR pooled screens, which discloses an expression construct comprising recombinant interferon α2 (IFNα2) mutants. This invention offers methods for utilizing IFNα2 mutants and their derivatives for treating cancer, infectious diseases, and autoimmune diseases.
Career Highlights
Diego Jaitin has worked with esteemed organizations such as the Weizmann Institute of Science and Yeda Research and Development & Co. Ltd. His experience in these institutions has allowed him to collaborate with leading scientists and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Gideon E Schreiber and Laila C Roisman. Their collaborative efforts have further advanced the research and applications of Jaitin's inventions.
Conclusion
Diego Jaitin's innovative work in RNA sequencing and cancer treatment exemplifies the impact of scientific research on healthcare. His patents and collaborations continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile